Lavaniya Kunalingam

Lavaniya Kunalingam has extensive experience in the field of biotechnology and pharmaceutical research. Lavaniya started their career at Bayer HealthCare as an intern in peptide synthesis and later worked as an intern in organic chemistry. After completing their internships, they joined The University of Auckland as a Master Thesis researcher in peptide chemistry. Lavaniya then worked as a Research Engineer at Institut Curie, focusing on organic synthesis and cell biology.

In 2017, Lavaniya joined AstraZeneca as an IMED Graduate Scientist, where they gained valuable experience in drug discovery and development. Following their time at AstraZeneca, they joined Anjarium Biosciences as a Senior Research Associate. In this role, they played a crucial part in planning and executing preclinical studies to compare lipid nanoparticles with hybridosomes as nano-carriers for mRNA delivery in the treatment of a lysosomal storage disease.

Currently, Lavaniya is working at Coave Therapeutics as a Principal Scientist, where they are involved in research and development. Lavaniya'swork focuses on developing new gene therapy approaches and validating their efficacy in vitro and in vivo. Lavaniya's contributions to the field have led to their being named co-inventor on several patents.

Overall, Lavaniya Kunalingam's work experience showcases their expertise and achievements in the fields of biotechnology and pharmaceutical research. Lavaniya has made significant contributions to the development of novel therapies and has a strong background in organic chemistry and drug discovery.

Lavaniya Kunalingam completed a Master's degree in Chemical Engineering from Ecole supérieure de Chimie organique et minérale from 2009 to 2015. Lavaniya also pursued a Master's degree in Organic Chemistry from Ecole Nationale Superieure de Chimie Mulhouse from 2014 to 2015.